Letzmove 125mg Tablet SR
By Letzmove
Rx
10 Tablet SR in a Strip

Composition
Diclofenac(125mg)

Manufacturer - Novartis India Ltd
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Expires on or after
June, 2026

liver
When using Letzmove 125mg Tablet SR, it is important to exercise caution if you have liver disease. Patients with liver issues may require a dose adjustment for this medication. It is advised to consult your doctor before starting this medication especially if you have liver disease. For patients with liver problems who are on a long-term course of Letzmove 125mg Tablet SR, regular monitoring of liver function tests is highly recommended to ensure safety and efficacy.

kidney
Letzmove 125mg Tablet SR needs caution in patients with kidney disease. Adjusting the dose may be necessary. Consult your doctor.

alcohol
Avoid drinking alcohol when taking Letzmove 125mg Tablet SR for safety reasons.

driving
When taking Letzmove 125mg Tablet SR, be cautious as it may cause side effects like headaches, blurred vision, dizziness, or drowsiness that could impair your ability to drive.

pregnancy
Letzmove 125mg Tablet SR is not safe to use during pregnancy due to potential risks to the developing baby. In rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Always consult your doctor.

breastfeeding
Letzmove 125mg Tablet SR is considered safe during breastfeeding based on limited data indicating no significant risk to the baby.
| Habit Forming | No |
| Chemical Class | Phenylacetic acid Derivative |
| Therapeutic Class | PAIN ANALGESICS |
| Action Class | NSAID's- Non-Selective COX 1&2 Inhibitors (acetic acid) |
₹129.06
₹143.4
10% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025
